Literature DB >> 28416962

Cutaneous Leukocytoclastic Vasculitis with Gastrointestinal Involvement after Anti-Tuberculosis Treatment.

Sangwoo Shim1, Chi Young Jung2.   

Abstract

Entities:  

Year:  2017        PMID： 28416962      PMCID： PMC5392493          DOI： 10.4046/trd.2017.80.2.210

Source DB:  PubMed          Journal:  Tuberc Respir Dis (Seoul)        ISSN： 1738-3536


× No keyword cloud information.
  5 in total

1.  The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis.

Authors:  L H Calabrese; B A Michel; D A Bloch; W P Arend; S M Edworthy; A S Fauci; J F Fries; G G Hunder; R Y Leavitt; J T Lie
Journal:  Arthritis Rheum       Date:  1990-08

2.  EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides.

Authors:  S Ozen; N Ruperto; M J Dillon; A Bagga; K Barron; J C Davin; T Kawasaki; C Lindsley; R E Petty; A M Prieur; A Ravelli; P Woo
Journal:  Ann Rheum Dis       Date:  2005-12-01       Impact factor: 19.103

3.  Cutaneous leukocytoclastic vasculitis associated with anti-tuberculosis drugs.

Authors:  Gülhadiye Avcu; Gülnar Sensoy; Mehmet Halil Çeliksoy; Ayhan Sogut; Mehmet Kefeli; Arzu Karli; Nursen Belet
Journal:  Pediatr Int       Date:  2015       Impact factor: 1.524

Review 4.  Cutaneous vasculitis update: diagnostic criteria, classification, epidemiology, etiology, pathogenesis, evaluation and prognosis.

Authors:  J Andrew Carlson; Bernard T Ng; Ko-Ron Chen
Journal:  Am J Dermatopathol       Date:  2005-12       Impact factor: 1.533

5.  Cutaneous leukocytoclastic vasculitis due to anti-tuberculosis medications, rifampin and pyrazinamide.

Authors:  Joo-Hee Kim; Jun-Il Moon; Jeong Eun Kim; Gil-Soon Choi; Hae-Sim Park; Young-Min Ye; Hyunee Yim
Journal:  Allergy Asthma Immunol Res       Date:  2009-12-30       Impact factor: 5.764
  5 in total
  1 in total

Review 1.  Ceftriaxone-induced leukocytoclastic vasculitis: a case report and literature review of antibiotic-induced leukocytoclastic vasculitis.

Authors:  Aseel A Almasoudi; Eman S Bablghaith; Samaher I Alaauldeen; Ayman M Falemban; Ahlam A Sherbeeni; Adeeb A Bulkhi
Journal:  J Int Med Res       Date:  2022-05       Impact factor: 1.573
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.